Our Mission

To reduce cancer burden through innovative, epidemiologic research.

Research Projects

Antineoplastic drugs: policy levers and opportunities for occupational exposure reduction

Dr. Peters and Dr. Brenner

Antineoplastic drugs, also known as cytotoxic or hazardous drugs, are necessary tools in cancer treatment. However, many antineoplastic drugs can also cause cancer later in life…

Late effects of childhood cancer

Dr. Fidler-Benaoudia

Although survival from childhood cancer has increased substantially in the last decades, treatments used to achieve cure are known to cause late effects, or health problems that occur months or years after treatment has ended…

Alberta Adolescent and Young Adult Cancer Survivor Study

Dr. Fidler-Benaoudia

The Alberta Adolescent and Young Adult Cancer Survivor Study is a population-based, retrospective cohort study that includes all individuals that were diagnosed with cancer between the ages of 15 and 39 years in Alberta from 1983 to 2017. The cohort includes nearly 25,000 adolescent and young adult (AYA) cancer survivors, …

The Department of Cancer Epidemiology and Prevention Research

Since 2001, the scientists of CEPR have been combining traditional epidemiologic study designs with a molecular epidemiologic emphasis. The collection of demographic, lifestyle, and clinical information has now been expanded to include genetic, cellular, biomarker and metabolomic information from collected biological specimens.

Latest News


CEPR Rounds

Date: November 26, 2020

Time: 11:00 - 12:00

Location: Zoom

Drs. Megan Highet and Jean-Christophe Boucher from ACPLF will be presenting the CEPR Rounds on November 26. Presentation Title: Mixed messages: interdisciplinary research to inform population and targeted interventions to increase HPV vaccine confidence via the virtual health setting. Brief Bios: Megan has been leading research on community health and social factors contributing to inequities…

CEPR Rounds

Date: December 3, 2020

Time: 11:00 - 12:00

Location: Zoom

Alberta’s Tomorrow Project – A Health Research Platform Jennifer Vena is the Scientific Director of Alberta’s Tomorrow Project, a longitudinal cohort study of 55,000 Albertans currently in its 20th year, that sits in Cancer Research & Analytics in CancerControl Alberta, Alberta Health Services. ATP functions as a health research platform, with the goal of supporting…

Please send us an email if you’d like more information about upcoming events.

Follow AHS-CancerCare on Twitter

Do You Have Questions?

Send us an email and we will be in touch with you shorty. If you’d like your email directed to one of our Research Scientists, please address the message to them and it will be forwarded.